CONCORDBIO Concord Biotech Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens CONCORDBIO is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about CONCORDBIO
Concord Biotech Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Concord Biotech Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Concord Biotech Ltd. is balanced between accumulation and distribution forces.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
CONCORDBIO — frequently asked questions
What is the Concord Biotech Ltd. share price today?
CONCORDBIO is trading at ₹1,329.20 (-0.43% vs previous close), per the latest update on this page.
What is the P/E ratio of Concord Biotech Ltd.?
CONCORDBIO (Concord Biotech Ltd.) has a trailing twelve-month P/E ratio of 53.5.
What is the market cap of Concord Biotech Ltd.?
CONCORDBIO has a market capitalisation of approximately ₹13,906 crore.
What is the ROE of Concord Biotech Ltd.?
CONCORDBIO has a return on equity (ROE) of about 13.5%.
Is CONCORDBIO near its 52-week high?
CONCORDBIO is trading -32.9% from its 52-week high of ₹1,980.00 as of 2026-07-21.
What is the RSI of CONCORDBIO?
The 14-day RSI of CONCORDBIO is 57.2, which is considered neutral.
Is CONCORDBIO above its 200-day moving average?
CONCORDBIO is trading above its 200-DMA of ₹1,275.49 (+4.2% away).
Are FIIs or big investors buying CONCORDBIO?
Strota tracks every bulk and block deal in CONCORDBIO with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.